PRP Dosing: Things to Know

PRP Dosing: Things to Know

Great bakers know that when it comes to delivering the best treats and sweets, you have to carefully measure your ingredients.

The same applies to Platelet Rich Plasma (PRP) therapy. The measured amount, the dosage, of concentrated platelets and other cells in the plasma, must be customized to each patient’s specific condition to achieve the best outcomes.

Platelet rich plasma uses highly concentrated platelets to speed up the healing process, decrease inflammation and stimulate tissue regeneration.  See our blog on PRP. As we go in-depth in the study of PRP, we now know that determining the best PRP  treatment is not just about how much platelets are in the injection.

Not All PRP are the same

There are other factors that need to be considered to obtain the best PRP treatment. There are other other cells in the PRP, specifically the red blood cells and white blood cells that need to be adjusted depending on the patient’s condition. Platelets release growth factors that facilitate the healing process. The timing and pattern of growth factor release and the individual’s cellular response to growth factors may vary. This can affect outcome and should be thought out in determining PRP treatment. There is a wide variety of methods used to harvest, process and deliver PRP therapy.  The resulting platelet count, cell composition and PRP quality are highly variable and can affect clinical outcome.

Only physicians truly experienced in using PRP know how to adjust the dosing appropriately. Joints, tendons, ligament and nerves require their own specific PRP formulation. Imagine if a doctor writes the incorrect kind and amount of antibiotic to treat your specific infection.  Patients should make sure that they do their homework in seeking skilled and experienced physicians providing their PRP treatment. These physicians should not only know how to provide the best customized PRP for your need, they should also be adept in the delivery of PRP therapy. These physicians should have advanced training in diagnostic ultrasound or fluoroscopic (xray) guided procedures to make the procedure safe, comfortable and effective.

Not all PRP dosing is the same. Patients should choose physicians who have the knowledge and expertise to ensure they get the right kind of PRP for their orthopedic condition.

Dr. Christopher J. Rogers and Dr Mary A. Ambach are experts and key leaders in the field of regenerative medicine.  They are board certified doctors with over 20 years of combined research and clinical experience in platelet rich plasma and other cell based therapies.

New Zealand Orthopedic Physician Visits San Diego Orthobiologics Medical Group To Observe Innovative Procedures

New Zealand Orthopedic Physician Visits San Diego Orthobiologics Medical Group To Observe Innovative Procedures

New Zealand Orthopedic Physician, Dr. Zaid Matti, Visits San Diego Orthobiologics Medical Group To Observe Innovative Procedures

We had the pleasure of having New Zealand physician, Dr. Matti visit our medical clinic. Dr Matti was able to observe our innovative treatments for patients with joint arthritis and low back pain. We had great discussions about platelet rich plasma, bone marrow concentrate and adipose derived cell therapies and how together we can move the field of Regenerative Medicine forward. Thank you, Dr. Matti, for your visit and sharing your insights with us!

Dr Mary Ambach as Guest Speaker for The Doctor’s Hour

Dr Mary Ambach as Guest Speaker for The Doctor’s Hour

Dr Mary Ambach as Guest Speaker for The Doctor’s Hour.

The Doctor’s Hour is a program for doctors to access resources and videos from experts in the pain management and regenerative medicine field. Dr Ambach shared her expertise with colleagues on the current evidence of stem cell therapies for joint pain, osteoarthritis and tendon injuries.

Annual SDARTs Conference 2019

Annual SDARTs Conference 2019

Annual Conference of The San Diego Academy

Dr. Ramon Llull and Dr. Chris Rogers

Dr. Rogers met and collaborated with thought leaders in the Annual Conference of The San Diego Academy of Regenerative Therapies (SDARTs) from August 2-4 in San Diego, CA. The annual SDARTs conference together pioneers and experts in regenerative medicine and offers training on many different applications of regenerative medicine across different medical specialty fields. At San Diego Orthobiolgoics Medical Group, we continue to learn innovative procedures to find the best treatment options for our patients!

Clinical Trial Announced: Knee Osteoarthritis

Clinical Trial Announced: Knee Osteoarthritis

Dr. Christopher Rogers and Dr. Mary Ambach are proud to announce that San Diego Orthobiologics Medical Group is leading a multi-center clinical trial for the treatment of knee osteoarthritis. Click for details. https://personalizedstemcells.com

 

Pin It on Pinterest